Injectable particle
US9168226B1 · kind B1 · utility
2Cited by
0References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 7, 2015 |
| Grant date | Oct 27, 2015 |
| Priority date | — |
| Expiry date | Aug 7, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an injectable particle comprising dasatinib acetate and a hyaluronic acid. The hyaluronic acid may be acetylated or sulfated. The particle is for the use of cancer therapy. The injectable particle may further comprises an acid, wherein the acid is dispersed evenly in the matrix of the injectable particle.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.